Showing results (281-290 of 288) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 288 results.
Molecular Pharmacology|May 1, 1996
Ahr locus phenotype in congenic mice influences hepatic and pulmonary DNA adduct levels of 2-amino-3-methylimidazo[4,5-f]quinoline in the absence of cytochrome P450 inductionP V Nerurkar, H A Schut, L M Anderson, et al.
Cancer Research|September 18, 2001
Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesisY H Im, H T Kim, I Y Kim, et al.
Carcinogenesis|May 20, 1999
Histopathology and gene expression changes in rat liver during feeding of fumonisin B1, a carcinogenic mycotoxin produced by Fusarium moniliformeE R Lemmer, P de la Motte Hall, N Omori, et al.
Electrophoresis|March 22, 2000
Identification of gel-separated tumor marker proteins by mass spectrometryA C Bergman, T Benjamin, A Alaiya, et al.
Oncogene|January 20, 2015
Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinomaX Zhao, S Parpart, A Takai, et al.
Oncogene|April 19, 2011
Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic responseY-H Lee, A D Judge, D Seo, et al.
Oncogene|July 25, 2012
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomasP Wang, Q Dong, C Zhang, et al.
Neurobiology of Disease|February 3, 2007
Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams SyndromeJ M van Hagen, J N van der Geest, R S van der Giessen, et al.
Pageof 29